首页> 外文OA文献 >Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

【2h】

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

机译：非聚乙二醇脂质体阿霉素联合吉西他滨作为转移性或局部晚期乳腺癌的一线治疗。 I / II期试验的最终结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Barco, S.; Colomer, R.; Calvo, L.; Tusquets, I.; Adrover, E.; Sánchez, P.; Rifà, J.; Haba, J.; Virizuela, J. A.;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial. [J] . Del Barco S, Colomer R, Calvo L Breast cancer research and treatment. . 2009,第2期

机译：非聚乙二醇脂质体阿霉素联合吉西他滨作为转移性或局部晚期乳腺癌的一线治疗。 I / II期试验的最终结果。
3. A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer. [J] . Amadori D, Milandri C, Comella G, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2011,第14期

机译：非聚乙二醇脂质体阿霉素，多西紫杉醇和曲妥珠单抗作为HER-2阳性局部晚期或转移性乳腺癌的一线治疗的I / II期试验。
4. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX(TM)/Doxil((R))) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. [J] . OBrien ME, Wigler N, Inbar M, Annals of oncology: official journal of the European Society for Medical Oncology . 2004,第3期

机译：与传统的阿霉素相比，聚乙二醇化脂质体阿霉素HCl（CAELYXTM / Doxil（R））的III期试验具有更低的心脏毒性和相当的疗效，可用于转移性乳腺癌的一线治疗。
5. Acoustic Cluster Therapy displays theranostic capability in enhancing the effectiveness of liposomal doxorubicin treatment of human triple negative breast cancer in mice [C] . Nigel Bush, Andrew Healey, Anant Shah, IEEE International Ultrasonics Symposium . 2019

机译：声学聚类疗法在提高小鼠中提高人类三重阴性乳腺癌的脂质体Doxorubicin治疗的有效性方面的治疗能力
6. Diffusion-weighted magnetic resonance imaging in monitoring treatment response in patients with locally advanced breast cancer. [D] . Singer, Lisa. 2010

机译：扩散加权磁共振成像可监测局部晚期乳腺癌患者的治疗反应。
7. A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study [O] . Patrizia Vici, Giuseppe Colucci, Francesco Giotta, 2011

机译：表柔比星/长春瑞滨与聚乙二醇化脂质体阿霉素/长春瑞滨作为晚期乳腺癌的一线治疗的多中心前瞻性II期随机试验。 GOIM研究
8. Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06) [O] . Rochlitz, C., Ruhstaller, T., Lerch, S., 2017

机译：贝伐单抗和每周两次的聚乙二醇化脂质体阿霉素的组合作为局部复发或转移性乳腺癌的一线治疗。多中心单臂II期临床试验（SAKK 24/06）

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅